The latest closing stock price for Palvella Therapeutics as of January 30, 2025 is 13.50.
An investor who bought $1,000 worth of Palvella Therapeutics stock at the IPO in 2015 would have $-954 today, roughly -1 times their original investment - a -26.46% compound annual growth rate over 10 years.
The all-time high Palvella Therapeutics stock closing price was 756.00 on February 13, 2018.
The Palvella Therapeutics 52-week high stock price is 22.32, which is 65.3% above the current share price.
The Palvella Therapeutics 52-week low stock price is 6.20, which is 54.1% below the current share price.
The average Palvella Therapeutics stock price for the last 52 weeks is 13.85.
An investor who bought $1,000 worth of Palvella Therapeutics stock at the IPO in 2015 would have $-954 today, roughly -1 times their original investment - a -26.46% compound annual growth rate over 10 years.
The all-time high Palvella Therapeutics stock closing price was 756.00 on February 13, 2018.
The Palvella Therapeutics 52-week high stock price is 22.32, which is 65.3% above the current share price.
The Palvella Therapeutics 52-week low stock price is 6.20, which is 54.1% below the current share price.
The average Palvella Therapeutics stock price for the last 52 weeks is 13.85.